Yokota K - Search Results

1

Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K. Ayada K, et al. Among authors: yokota k. Clin Rev Allergy Immunol. 2009 Aug;37(1):44-8. doi: 10.1007/s12016-008-8097-7. Clin Rev Allergy Immunol. 2009. PMID: 18985284 Review.

2

The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin.

Fujinaga Y, Inoue K, Watanabe S, Yokota K, Hirai Y, Nagamachi E, Oguma K. Fujinaga Y, et al. Among authors: yokota k. Microbiology (Reading). 1997 Dec;143 ( Pt 12):3841-3847. doi: 10.1099/00221287-143-12-3841. Microbiology (Reading). 1997. PMID: 9421908 Free article.

3

Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1).

Inoue K, Fujinaga Y, Honke K, Yokota K, Ikeda T, Ohyama T, Takeshi K, Watanabe T, Inoue K, Oguma K. Inoue K, et al. Among authors: yokota k. Microbiology (Reading). 1999 Sep;145 ( Pt 9):2533-2542. doi: 10.1099/00221287-145-9-2533. Microbiology (Reading). 1999. PMID: 10517606 Free article.

4

Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin.

Mahmut N, Inoue K, Fujinaga Y, Hughes L, Arimitsu H, Sakaguchi Y, Ohtsuka A, Murakami T, Yokota K, Oguma K. Mahmut N, et al. Among authors: yokota k. J Med Microbiol. 2002 Apr;51(4):286-294. doi: 10.1099/0022-1317-51-4-286. J Med Microbiol. 2002. PMID: 11926732

5

[Endotoxin (lipopolysaccharide) of Helicobacter pylori and gastric mucosal injury].

Hirai Y, Matsuura M, Hayashi S, Yokota K, Oguma K. Hirai Y, et al. Among authors: yokota k. Nihon Rinsho. 2002 Feb;60 Suppl 2:113-8. Nihon Rinsho. 2002. PMID: 11979761 Review. Japanese. No abstract available.

6

[Bacteriology of H. pylori].

Oguma K, Yokota K, Hirai Y, Hayashi S. Oguma K, et al. Among authors: yokota k. Nihon Rinsho. 2002 Feb;60 Suppl 2:74-83. Nihon Rinsho. 2002. PMID: 11979881 Japanese. No abstract available.

7

Reinfection rate following effective therapy against Helicobacter pylori infection in Japan.

Adachi M, Mizuno M, Yokota K, Miyoshi M, Nagahara Y, Maga T, Ishiki K, Inaba T, Okada H, Oguma K, Tsuji T. Adachi M, et al. Among authors: yokota k. J Gastroenterol Hepatol. 2002 Jan;17(1):27-31. doi: 10.1046/j.1440-1746.2002.02666.x. J Gastroenterol Hepatol. 2002. PMID: 11987263

8

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.

Inaba T, Mizuno M, Kawai K, Yokota K, Oguma K, Miyoshi M, Take S, Okada H, Tsuji T. Inaba T, et al. Among authors: yokota k. J Gastroenterol Hepatol. 2002 Jul;17(7):748-53. doi: 10.1046/j.1440-1746.2002.02790.x. J Gastroenterol Hepatol. 2002. PMID: 12121503 Clinical Trial.

9

Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.

Mahmut N, Inoue K, Fujinaga Y, Arimitsu H, Sakaguchi Y, Hughes L, Hirst R, Murphy T, Tsuji T, Watanabe T, Ohyama T, Karasawa T, Nakamura S, Yokota K, Oguma K. Mahmut N, et al. Among authors: yokota k. J Med Microbiol. 2002 Oct;51(10):813-820. doi: 10.1099/0022-1317-51-10-813. J Med Microbiol. 2002. PMID: 12435059

10

Outcome of patients with inconsistent results from 13C-urea breath test and bacterial culture at the time of assessment of Helicobacter pylori eradication therapy in Japan.

Nagahara Y, Mizuno M, Maga T, Ishiki K, Okuno T, Yoshida T, Yokota K, Oguma K, Okada H, Tsuji T. Nagahara Y, et al. Among authors: yokota k. Hepatogastroenterology. 2003 Sep-Oct;50(53):1700-3. Hepatogastroenterology. 2003. PMID: 14571821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,406 results

Search Page